JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB207086

Anti-Cathepsin K antibody [EPR19992]

Be the first to review this product! Submit a review

|

(14 Publications)

Anti-Cathepsin K antibody [EPR19992] (ab207086) is a rabbit monoclonal antibody detecting Cathepsin K in Western Blot, IHC-P. Suitable for Human.

- Biophysical QC for unrivalled batch-batch consistency

View Alternative Names

CTSO, CTSO2, CTSK, Cathepsin K, Cathepsin O, Cathepsin O2, Cathepsin X

4 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cathepsin K antibody [EPR19992] (AB207086)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cathepsin K antibody [EPR19992] (AB207086)

Immunohistochemical analysis of paraffin-embedded human ovary cancer tissue labeling Cathepsin K with ab207086 at 1/1000 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.

Cytoplasmic staining on human ovary cancer is observed [PMID : 27076854].

Counter stained with Hematoxylin.

Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.

Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cathepsin K antibody [EPR19992] (AB207086)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cathepsin K antibody [EPR19992] (AB207086)

Immunohistochemical analysis of paraffin-embedded human osteosarcoma tissue labeling Cathepsin K with ab207086 at 1/1000 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.

Cytoplasmic staining on osteoclasts of human osteosarcoma is observed [PMID : 17559135].

Counter stained with Hematoxylin.

Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.

Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.

Western blot - Anti-Cathepsin K antibody [EPR19992] (AB207086)
  • WB

Supplier Data

Western blot - Anti-Cathepsin K antibody [EPR19992] (AB207086)

Blocking/Dilution buffer : 5% NFDM/TBST.

All lanes:

Western blot - Anti-Cathepsin K antibody [EPR19992] (ab207086) at 1/1000 dilution

All lanes:

Human bone giant cell tumor lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/50000 dilution

Predicted band size: 37 kDa

Observed band size: 27 kDa,37 kDa

false

Exposure time: 1s

Western blot - Anti-Cathepsin K antibody [EPR19992] (AB207086)
  • WB

CiteAb

Western blot - Anti-Cathepsin K antibody [EPR19992] (AB207086)

Cathepsin K western blot using anti-Cathepsin K antibody [EPR19992] ab207086. Publication image and figure legend from Suzuki, M., Takahashi, N., et al., 2020, Sci Rep, PubMed 31937805.

ab207086 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab207086 please see the product overview.

Suppressive effects of HMW-HA on enhanced cathepsin K expression induced by CTS loading at 1 Hz and 20% elongation for 24 hours. Pre-treatment with HA dose-dependently suppressed cathepsin K mRNA expression with statistical significance at a concentration of 1 mg/mL. (A) Pre-treatment with HA significantly suppressed the enhanced cathepsin K mRNA and protein expression induced by CTS loading for 24 hours, as compared to the sample without HA pre-treatment. Cathepsin K protein expression was also enhanced with CTS loading, as compared to the untreated sample cultured for 24 hours, as demonstrated by Western blot analysis. (B) The suppressive effect of HA was cancelled by pre-treatment with anti-CD44 antibody for one hour, whereas no significant effect was observed with anti-ICAM-1 antibody pre-treatment (*p < 0.05) (C).

false

  • Carrier free

    Anti-Cathepsin K antibody [EPR19992] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR19992

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

IHC-P, WB

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/1000", "IHCP-species-notes": "<p></p>" } } }

Product details

What is this antibody validated in?
Anti-Cathepsin K antibody [EPR19992] (ab207086) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Immunohistochemistry (IHC-P) in Human samples.

What is the molecular weight of Cathepsin K?
Anti-Cathepsin K [EPR19992] (ab207086) specifically detects a band for Cathepsin K (UniProt: P43235) at a molecular weight of 37kDa.

Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies.

Other related products
We have a range of other formats of antibody clone [EPR19992] also available for your convenience: ab207086, Carrier free - ab223140

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Cathepsin K also known as CTSK is a protease enzyme that belongs to the papain family of cysteine proteases. With a molecular weight of approximately 37 kDa Cathepsin K is mainly expressed in osteoclasts which are cells involved in bone resorption. This enzyme functions by cleaving collagen a vital component of bone extracellular matrix which facilitates bone remodeling and turnover. Known for its collagenolytic activity Cathepsin K is important in processes where breakdown of collagen fibers is required.
Biological function summary

Cathepsin K plays a significant role in bone metabolism. It operates within the osteoclasts where it degrades type I collagen and other matrix proteins essential for normal bone maintenance and repair. Cathepsin K does not function as part of a complex but acts independently in its enzymatic role. It is highly specific to substrates found in the bone matrix differentiating it from other cathepsins like cathepsin L or B that may have broader expression and role.

Pathways

Cathepsin K is an important player in the bone remodeling pathway. This pathway involves a series of coordinated actions between osteoclasts and osteoblasts to maintain bone health. Cathepsin K's activity is tightly regulated within this pathway to ensure proper bone density and structure. It is associated with other proteins such as osteopontin and matrix metalloproteinases which work together to modulate bone turnover. Within the RANK/RANKL pathway Cathepsin K acts as a downstream effector following osteoclast activation by RANKL.

Cathepsin K is most notably linked to osteoporosis and pycnodysostosis. Osteoporosis arises due to excessive bone resorption where elevated Cathepsin K activity leads to weakened bone structure increasing fracture risk. Pycnodysostosis is a rare genetic disorder caused by mutations in the gene coding for Cathepsin K resulting in impaired bone resorption and abnormally dense but brittle bones. In these conditions proteins such as RANKL and osteoprotegerin also play critical roles by influencing osteoclast differentiation and activity thereby modulating Cathepsin K's effects.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Thiol protease involved in osteoclastic bone resorption and may participate partially in the disorder of bone remodeling. Displays potent endoprotease activity against fibrinogen at acid pH. May play an important role in extracellular matrix degradation. Involved in the release of thyroid hormone thyroxine (T4) by limited proteolysis of TG/thyroglobulin in the thyroid follicle lumen (PubMed : 11082042).
See full target information CTSK

Publications (14)

Recent publications for all applications. Explore the full list and refine your search

Journal of neuroinflammation 22:207 PubMed40859333

2025

Disrupted betaine metabolism drives Th17 cell differentiation, mediating methamphetamine-induced depressive behaviors in male mice.

Applications

Unspecified application

Species

Unspecified reactive species

Rongji Hui,Jiabao Xu,Hongchen Ma,Tao Feng,Congcong Hou,Xintao Wang,Mingyang Jin,Feng Yu,Yan Shi,Bing Xie,Ludi Zhang,Bin Cong,Chunling Ma,Di Wen

Stem cell research & therapy 16:79 PubMed39985080

2025

Human dental follicle stem cell-derived exosomes reduce root resorption by inhibiting periodontal ligament cell pyroptosis.

Applications

Unspecified application

Species

Unspecified reactive species

Xinyi Li,Xinyang Liu,Jianing Zhou,Ping Zhang,Song Chen,Ding Bai

Cancer letters 611:217443 PubMed39755363

2025

Role of Cathepsin K in bone invasion of pituitary adenomas: A dual mechanism involving cell proliferation and osteoclastogenesis.

Applications

Unspecified application

Species

Unspecified reactive species

Hongyan Liu,Peng Wang,Jie Li,Jian Zhao,Yiming Mu,Weijun Gu

Cell biology international 48:1343-1353 PubMed38934258

2024

Ginsenoside Rb3 alleviates the formation of osteoclasts induced by periodontal ligament fibroblasts in the periodontitis microenvironment through the STAT3 pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Yuhua Zhang,Hanping Shi

Aging 16:12498-12509 PubMed38747738

2024

SHP2 mediates STAT3/STAT6 signaling pathway in TAM to inhibit proliferation and metastasis of lung adenocarcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Guojing Chai,Yingbo Nan,Haili Zhao,Qingchuan Hu

Frontiers in oral health 4:1308657 PubMed38152410

2023

The protective role of CD73 in periodontitis: preventing hyper-inflammatory fibroblasts and driving osteoclast energy metabolism.

Applications

Unspecified application

Species

Unspecified reactive species

Erivan S Ramos-Junior,Shantiece Dawson,Weston Ryan,Braden Clinebell,Rogelio Serrano-Lopez,Marsha Russell,Rylee Brumbaugh,Roger Zhong,Jussara Gonçalves Fernandes,Luciana M Shaddox,Christopher W Cutler,Ana Carolina Morandini

BMC oral health 23:265 PubMed37158847

2023

IRAK4 inhibition: an effective strategy for immunomodulating peri-implant osseointegration via reciprocally-shifted polarization in the monocyte-macrophage lineage cells.

Applications

Unspecified application

Species

Unspecified reactive species

Juan Zhao,Jia Li,Antian Xu,Yangbo Xu,Fuming He,Yingjie Mao

Frontiers in oncology 12:901647 PubMed36052250

2022

Expression and clinical significance of Cathepsin K and MMPs in invasive non-functioning pituitary adenomas.

Applications

Unspecified application

Species

Unspecified reactive species

Hongyan Liu,Saichun Zhang,Ting Wu,Zhaohui Lv,Jianming Ba,Weijun Gu,Yiming Mu

Cell discovery 8:66 PubMed35821117

2022

Single-cell atlas of keratoconus corneas revealed aberrant transcriptional signatures and implicated mechanical stretch as a trigger for keratoconus pathogenesis.

Applications

Unspecified application

Species

Unspecified reactive species

Shengqian Dou,Qun Wang,Bin Zhang,Chao Wei,Huijin Wang,Ting Liu,Haoyun Duan,Hui Jiang,Mingna Liu,Xiaolin Qi,Qingjun Zhou,Lixin Xie,Weiyun Shi,Hua Gao

American journal of translational research 14:3559-3571 PubMed35702106

2022

Duhuo Jisheng Decoction inhibits the activity of osteoclasts in osteonecrosis of the femoral head via regulation of the RELA/AKT1 axis.

Applications

Unspecified application

Species

Unspecified reactive species

Tao Xing,Yongqiang Zhao,Jun Zhao,Zhenxing Jiang,Yingshuan Zhang,Shenghua Li
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com